110 related articles for article (PubMed ID: 1462876)
1. The bradykinin antagonist Hoe 140 inhibits carrageenan- and thermically induced paw oedema in rats.
Wirth KJ; Alpermann HG; Satoh R; Inazu M
Agents Actions Suppl; 1992; 38 ( Pt 3)():428-31. PubMed ID: 1462876
[TBL] [Abstract][Full Text] [Related]
2. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
Campos MM; Henriques MG; Calixto JB
Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
[TBL] [Abstract][Full Text] [Related]
3. Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation.
Félétou M; Lonchampt M; Robineau P; Jamonneau I; Thurieau C; Fauchère JL; Villa P; Ghezzi P; Prost JF; Canet E
J Pharmacol Exp Ther; 1995 Jun; 273(3):1078-84. PubMed ID: 7791078
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice.
Corrêa CR; Kyle DJ; Chakraverty S; Calixto JB
Br J Pharmacol; 1996 Feb; 117(3):552-558. PubMed ID: 8821548
[TBL] [Abstract][Full Text] [Related]
5. Interactive contribution of NK(1) and kinin receptors to the acute inflammatory oedema observed in response to noxious heat stimulation: studies in NK(1) receptor knockout mice.
Rawlingson A; Gerard NP; Brain SD
Br J Pharmacol; 2001 Dec; 134(8):1805-13. PubMed ID: 11739258
[TBL] [Abstract][Full Text] [Related]
6. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
[TBL] [Abstract][Full Text] [Related]
7. Oral antinociception and oedema inhibition produced by NPC 18884, a non-peptidic bradykinin B2 receptor antagonist.
de Campos RO; Alves RV; Ferreira J; Kyle DJ; Chakravarty S; Mavunkel BJ; Calixto JB
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):278-86. PubMed ID: 10543429
[TBL] [Abstract][Full Text] [Related]
8. Influence of a long-acting bradykinin antagonist, Hoe 140, on some acute inflammatory reactions in the rat.
Damas J; Remacle-Volon G
Eur J Pharmacol; 1992 Jan; 211(1):81-6. PubMed ID: 1618271
[TBL] [Abstract][Full Text] [Related]
9. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
Griesbacher T; Legat FJ
Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701
[TBL] [Abstract][Full Text] [Related]
10. A bradykinin antagonist inhibits carrageenan edema in rats.
Burch RM; DeHaas C
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):189-93. PubMed ID: 2234103
[TBL] [Abstract][Full Text] [Related]
11. Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies.
Wirth K; Hock FJ; Albus U; Linz W; Alpermann HG; Anagnostopoulos H; Henk S; Breipohl G; König W; Knolle J
Br J Pharmacol; 1991 Mar; 102(3):774-7. PubMed ID: 1364852
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin effects in guinea pig tracheal epithelial cells are mediated through a B2 kinin receptor and can be inhibited by the selective antagonist Hoe 140.
Proud D; Reynolds CJ; Broomfield J; Goldman DW; Bathon JM
J Pharmacol Exp Ther; 1993 Mar; 264(3):1124-31. PubMed ID: 8383737
[TBL] [Abstract][Full Text] [Related]
14. The anti-inflammatory effects of 2 Hz electroacupuncture with different intensities on acute carrageenan-induced inflammation in the rat paw.
Lee JH; Choi YH; Choi BT
Int J Mol Med; 2005 Jul; 16(1):99-102. PubMed ID: 15942684
[TBL] [Abstract][Full Text] [Related]
15. W-7 (a calmodulin antagonist) inhibits carrageenan-induced paw edema in intact and adrenalectomized rats.
Khaksari M; Shamsizadeh A; Azarang A; Mahmoodi M
Pak J Pharm Sci; 2007 Jul; 20(3):195-9. PubMed ID: 17545103
[TBL] [Abstract][Full Text] [Related]
16. TEMPOL, a membrane-permeable radical scavenger, attenuates peroxynitrite- and superoxide anion-enhanced carrageenan-induced paw edema and hyperalgesia: a key role for superoxide anion.
Khattab MM
Eur J Pharmacol; 2006 Oct; 548(1-3):167-73. PubMed ID: 16973155
[TBL] [Abstract][Full Text] [Related]
17. Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140.
Griesbacher T; Tiran B; Lembeck F
Br J Pharmacol; 1993 Feb; 108(2):405-11. PubMed ID: 8448591
[TBL] [Abstract][Full Text] [Related]
18. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
19. Effect of Ginkgo biloba extract on carrageenan-induced acute local inflammation in gamma irradiated rats.
Hedayat I; Salam OM; Baiuomy AR
Pharmazie; 2005 Aug; 60(8):614-9. PubMed ID: 16124406
[TBL] [Abstract][Full Text] [Related]
20. Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation.
Asano M; Hatori C; Inamura N; Sawai H; Hirosumi J; Fujiwara T; Nakahara K
Br J Pharmacol; 1997 Dec; 122(7):1436-40. PubMed ID: 9421292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
